United States National Library of Medicine National Institutes of Health

2009AA Micromedex Source Information

Web site:
http://www.micromedex.com/products/drugdex/

Authority
The DRUGDEX® System is produced by Micromedex®, a healthcare brand of Thomson Reuters.

Purpose
The purpose of DRUGDEX is to allow easy access to current, accurate drug knowledge.

Description
DRUGDEX covers FDA-approved and investigational prescription and nonprescription drugs, as well as non-U.S. preparations. Areas covered include dosage, pharmacokinetics, cautions, interactions, clinical applications, adverse effects, comparative efficacy, drug of choice information, and orphan drug status.

Metathesaurus Scope
The Metathesaurus representation of DRUGDEX only contains information on clinical drugs.

The Metathesaurus representation of DRUGDEX contains information on approximately 10,286 clinical drugs.

Audience
The intended audiences for DRUGDEX are:

  • Health care professionals who prescribe, order, dispense, administer, or research drugs
  • Drug safety and information professionals
  • Research and development
  • Medical affairs professionals
  • Medical and pharmacy school faculty and students

Update Frequency
DRUGDEX is updated weekly.

Metathesaurus Update Frequency
DRUGDEX is updated in each Metathesaurus release as part of RxNorm.

Sites Consulted

  1. Micromedex [Internet]. Thomson Reuters Healthcare Community. DRUGDEX system; [cited 2008 Sep 18]. . Available from: http://www.micromedex.com/products/drugdex/.

Last reviewed: 22 April 2009
Last updated: 22 April 2009
First published: 22 April 2009
Metadata| Permanence level: Permanence Not Guaranteed